Compared to NTC cells, CD147 knockdown A6 cells had a much lower tumor incidence (2/8 vs. 5/8), an increased median tumor formation time (>44 vs. 25 days), and significantly smaller tumors (77.05–81.72% reduction between Day 20 and Day 44, Supplementary Figure S4B). The gene discussed is BSG; the disease is neoplasm.